EDGAR Filing Documents for 0001181431-15-006884

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001181431-15-006884

Filing Date

2015-05-13

Accepted

2015-05-13 19:16:01

Documents

Period of Report

2015-05-13

Document Format Files

Seq	Description	Document	Type	Size
1		rrd424960.html	4
1		rrd424960.xml	4	6215
	Complete submission text file	0001181431-15-006884.txt		7599

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269

Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15859846